RECK and metabolic dysfunction-associated steatohepatitis: Using an in vitro cell culture model employing isolated mouse primary hepatocytes, Dashek et al. (2022) tested whether the induction of RECK expression inhibited proinflammatory amphiregulin and EGFR signaling, the progression of NASH, and the development of HCC.